Drug profile · INN
fluorouracil
APOC-5FU
fluorouracil (APOC-5FU) is a thymidylate synthase inhibitor. Associated with Alphapharm Pty Ltd. Route of administration: topical. Current US regulatory status: approved.
Drug details — fluorouracil
- US status
- approved
- Class
- —
- Route
- TOPICAL
- Patents
- 2
- Programs
- 121
- Data quality
- 0.89
Quick answer
fluorouracil (APOC-5FU) is a thymidylate synthase inhibitor. Associated with Alphapharm Pty Ltd. Route of administration: topical. Current US regulatory status: approved.
Key facts
Mechanism of action
Thymidylate synthase inhibitor
Primary target: DNA
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
| TGA | approved | — |
| NMPA | clinical trials | — |
Pipeline programs
Related & competitor drugs
Related patents
Frequently asked questions
What is fluorouracil?
fluorouracil (APOC-5FU) is a thymidylate synthase inhibitor. Associated with Alphapharm Pty Ltd. Route of administration: topical. Current US regulatory status: approved.
What is the brand name for fluorouracil?
APOC-5FU is a marketed brand name for fluorouracil. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of fluorouracil?
fluorouracil has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.